UCLA School of Nursing

Shockwave Medical Appoints Nick West as Associate Chief Medical Officer

Retrieved on: 
Tuesday, September 12, 2023
Green Lane Hospital, Plaque, FRCP, University, Shock wave, Charing Cross Hospital Medical School, UCLA School of Nursing, Trinity Hall, University of Cambridge, FACC, Cardiovascular disease, Medicine, CMO, Associate, IVL, Congress, John Radcliffe Hospital, Royal Papworth Hospital NHS Foundation Trust, Divisional patent application, European Innovation Council, Cardiology, Royal Papworth Hospital, European Society of Cardiology, FESC, Nursing, Medical device, MD

SANTA CLARA, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that Nick West, MA, MD, FRCP, FESC, FACC, has joined the company in the role of Associate Chief Medical Officer.

Key Points: 
  • SANTA CLARA, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that Nick West, MA, MD, FRCP, FESC, FACC, has joined the company in the role of Associate Chief Medical Officer.
  • Dr. West will report to Keith Dawkins, MD, Chief Medical Officer, and will be based in Santa Clara, with plans to succeed Dr. Dawkins as CMO in mid-2024.
  • West brings to Shockwave a wealth of expertise in the interventional cardiology space,” said Dr. Dawkins.
  • He is a founding member and Chief Medical Officer of the Cambridge-based vulnerable plaque startup, PlaqueTec Ltd, and sits on the Innovation Council of the UCLA School of Biodesign.

The Beryl Institute Announces 7 New Strategic Advisory Board Members

Retrieved on: 
Wednesday, September 13, 2023
LCSW, Central Waqf Council, Strategic Advisory Group of Experts, UCLA School of Nursing, Doctor of Philosophy, Strategic Advisory Board for Intellectual Property Policy, UCLA Health, Patient, Veterans' affairs, Nursing, Growth, Management

NASHVILLE, Tenn. , Sept. 13, 2023 /PRNewswire-PRWeb/ -- Strengthening its dedication to the growth of the patient experience across the continuum of care, The Beryl Institute welcomes new members to its Strategic Advisory Board. The Strategic Advisory Board serve as a key advisor to operations of The Beryl Institute. The board provides practical advice on strategy, growth opportunities and future plans, along with valuable insights into market and industry trends.

Key Points: 
  • NASHVILLE, Tenn. , Sept. 13, 2023 /PRNewswire-PRWeb/ -- Strengthening its dedication to the growth of the patient experience across the continuum of care, The Beryl Institute welcomes new members to its Strategic Advisory Board .
  • The Strategic Advisory Board serve as a key advisor to operations of The Beryl Institute.
  • Joining the previous 11 members, new members of the Strategic Advisory Board include:
    Karen Grimley, PhD, Chief Nursing Executive and Assistant Dean, UCLA Health and UCLA School of Nursing
    -Jennifer Purdy, LCSW, CPXP, Executive Director, CX Tools and Implementation Veterans Experience Office, Dept.
  • of Veterans Affairs
    "We are honored to engage these new members and the diversity of voices they represent - from patients, professionals and executives around the world - to our Strategic Advisory Board," said Jason Wolf, Ph.D., CPXP, President and CEO of The Beryl Institute.

Research Solutions Announces Engagement of Jeremy Murphy to Board of Directors

Retrieved on: 
Tuesday, September 5, 2023
Murphy, American Bankruptcy Institute Law Review, Natural language processing, Travel, Today (American TV program), The New York Times, Software, UCLA School of Nursing, Gulf Bank of Kuwait, MBA, Research, UCLA Anderson School of Management, Organization, Goldman Sachs, UCLA School of Law, Acquisition, Investment, Risk, Ideation, K, UCLA, TheSuitest, Management, Economics

HENDERSON, Nev., Sept. 5, 2023 /PRNewswire/ -- Research Solutions (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, announced today the engagement of Jeremy Murphy to the Research Solutions Board of Directors, effective immediately. Mr. Murphy will join the board as an advisor and observer, and he will be part of our board slate for the 2023 annual meeting.

Key Points: 
  • Jeremy Murphy, COO & President at ClickTripz, LLC, and formerly Goldman Sachs, to join Research Solutions' Board of Directors as Advisor and Observer
    HENDERSON, Nev., Sept. 5, 2023 /PRNewswire/ -- Research Solutions (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, announced today the engagement of Jeremy Murphy to the Research Solutions Board of Directors, effective immediately.
  • Mr. Murphy will join the board as an advisor and observer, and he will be part of our board slate for the 2023 annual meeting.
  • Following the appointment of Mr. Murphy, the Board will comprise six directors, four of whom are independent.
  • "We are pleased to welcome Jeremy Murphy to the Research Solutions Board," said Roy W. Olivier, CEO of Research Solutions.

Wilson Sonsini Adds Karen Deschaine as a Partner in San Diego as the Firm Continues to Grow Its Corporate Life Sciences Practice

Retrieved on: 
Monday, July 31, 2023
Legal, Science, Professional Services, Other Science, United States service academies, Wilson Sonsini Goodrich & Rosati, San Diego Business Journal, Therapy, UCLA School of Law, Private law, Incubator, UCLA School of Nursing, Biotechnology, Multimedia, Genomics, Proteomics, Auburn University, Silicon, Cooley, Cooley LLP, United States Department of the Army, Health, Drug discovery, Pharmaceutical industry, Fine chemical

Deschaine has an established corporate practice focused on representing life sciences clients, particularly biotechnology and therapeutics companies.

Key Points: 
  • Deschaine has an established corporate practice focused on representing life sciences clients, particularly biotechnology and therapeutics companies.
  • Her addition reflects Wilson Sonsini’s successful and ongoing efforts to expand its corporate life sciences practice.
  • View the full release here: https://www.businesswire.com/news/home/20230731127119/en/
    Over the course of 15-plus years, Deschaine has developed a sophisticated “company-building” corporate life sciences practice.
  • “We continue to advance in our strategic efforts to expand our corporate life sciences practice, and Karen’s addition in San Diego, a leading life sciences market, is another stride forward,” said Doug Clark , managing partner at Wilson Sonsini.

HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ: IVCP) With Goal to Transform Cardiovascular Disease Treatment

Retrieved on: 
Monday, April 24, 2023
Cardiology, Biotechnology, Pharmaceutical, Finance, Health, Asset Management, Professional Services, Other Health, Plaque, Wesley Clark, Cardiovascular disease, Cedars-Sinai Medical Center, UCLA School of Nursing, Stroke, Splenic infarction, Dean, HDL, Atherosclerosis, LOI, Death, Rupture, IVCP, Acquisition, Patient, Risk, Nursing, FDA, Therapy, Pharmaceutical industry

HDL Therapeutics’ platform, removes the highest risk plaques in coronary arteries that tend to rupture causing heart attacks and stroke.

Key Points: 
  • HDL Therapeutics’ platform, removes the highest risk plaques in coronary arteries that tend to rupture causing heart attacks and stroke.
  • Cardiovascular disease, including heart attacks, are the leading cause of death worldwide, taking an estimated 17.9 million lives annually.
  • In the United States, heart attacks were responsible for 132,968 deaths, and almost half of American adults have cardiovascular diseases.
  • "This proposed business combination will be a significant milestone for HDL Therapeutics and a breakthrough in the development of a whole new treatment paradigm for a fatal cardiovascular disease."

WesternU College of Podiatric Medicine celebrates 100% match rate for 10 consecutive years

Retrieved on: 
Thursday, March 23, 2023
Yee, Faculty, Perseverance, University, Camara, Western University College of Podiatric Medicine, Education, Friends, Jacob Labovitz, UCLA School of Dentistry, Tears, RCPS, Mentorship, Veterans Health Administration, Western University of Health Sciences, FACPM, Student, DPM, UCLA School of Nursing, Nursing, Outline of health sciences, CPM, Scripps Mercy Hospital, UCLA, FFPM, Family, Buster Guzzardo, Podiatry, Dentistry, Tourism, Western University

POMONA, Calif., March 23, 2023 /PRNewswire-PRWeb/ -- For graduating medical students in Western University of Health Sciences' College of Podiatric Medicine (CPM), Match Day is a transformative, life-changing moment. The anxiety-filled day begins with reflections of personal endurance, hard work and self-sacrifice that instantly changes to excitement, joy and smiles learning that their journey at WesternU has made their dream come true: becoming a physician.

Key Points: 
  • POMONA, Calif., March 23, 2023 /PRNewswire-PRWeb/ -- For graduating medical students in Western University of Health Sciences' College of Podiatric Medicine (CPM), Match Day is a transformative, life-changing moment.
  • Since 1976, the Central Application Service for Podiatric Residencies has coordinated this annual rite of passage for podiatric medical and surgical residencies.
  • CPM continues to keep its promise of leading the way in inspiring and preparing the next generation of podiatric physicians.
  • In a moment of reflection, College of Podiatric Medicine Dean Jonathan Labovitz, DPM, FACFAS, CHCQM, thought about the bigger picture of this accomplishment.

Iveric Bio Announces the Addition of Pravin U. Dugel, MD, to its Board of Directors

Retrieved on: 
Tuesday, January 3, 2023
Health, Other Science, Research, Science, Pharmaceutical, Optical, Biotechnology, UCLA School of Nursing, Geographic atrophy, Bascom Palmer Eye Institute, Partner (business rank), American Academy of Ophthalmology, AAO, Research, Knowledge, Residence hall director, Founding, ISEE, Patient, Faculty, American Academy, AMD, Keck School of Medicine of USC, Society, ASRS, USC Eye Institute, Columbia University, University, University of Southern California, Praveen, United Kingdom, David Geffen School of Medicine at UCLA, Doctor of Philosophy, Retina, ACP, Management, Pharmaceutical industry, MD, Czechoslovakia, Ophthalmology

IVERIC bio, Inc. (Nasdaq: ISEE) announced today the election of Pravin U. Dugel, MD, President of Iveric Bio, to its Board of Directors, effective as of January 1, 2023.

Key Points: 
  • IVERIC bio, Inc. (Nasdaq: ISEE) announced today the election of Pravin U. Dugel, MD, President of Iveric Bio, to its Board of Directors, effective as of January 1, 2023.
  • “On behalf of the entire Board of Directors, we are excited to have Pravin join our board during this pivotal time as the Company prepares for a potential approval and commercial launch of ACP in geographic atrophy,” stated Adrienne L. Graves, PhD, Chairman of the Board of Iveric Bio.
  • “Pravin is an exceptional leader whose skills as an executive and extensive knowledge as a retinal specialist provide a valued perspective that will enhance the collective experience of our Board,” stated Glenn P. Sblendorio, Chief Executive Officer of Iveric Bio.
  • “I enjoy working closely with Pravin and now look forward to working with him in his added role as a board member.

Morrison Foerster Adds Experienced Technology Transactions and Life Sciences Attorney Matthew Ferry as Partner in San Diego

Retrieved on: 
Tuesday, June 7, 2022
Woman, Leadership, UCLA School of Nursing, Lawyer, Veteran, Journal, Biotechnology, International Conference on Neutrino Physics and Astrophysics, IP, Patent, Berkeley, Morrison & Foerster, Private law, Environment, List of life sciences, Investment, University, The American Lawyer, Chambers, Growth, Hygiene, Minnesota Journal of Law, Science & Technology, Civil and political rights, Ferry, SAN, California Institute for Quantitative Biosciences, Industry, Small business, Culture, Health, Financial technology, Acıbadem Healthcare Group, UCLA School of Law, Fortune 500, Color, Pharmaceutical industry, Law, Physics, Technology

SAN DIEGO, June 7, 2022 /PRNewswire-PRWeb/ -- Morrison Foerster, a leading global law firm, is pleased to announce the arrival of Matthew Ferry as a partner in the firm's Life Sciences Transactions + Licensing and Technology Transactions Groups, based in San Diego. Ferry brings more than a decade of combined technology transactions, life sciences transactions, and licensing experience to Morrison Foerster.

Key Points: 
  • SAN DIEGO, June 7, 2022 /PRNewswire-PRWeb/ -- Morrison Foerster , a leading global law firm, is pleased to announce the arrival of Matthew Ferry as a partner in the firm's Life Sciences Transactions + Licensing and Technology Transactions Groups, based in San Diego.
  • Ferry brings more than a decade of combined technology transactions, life sciences transactions, and licensing experience to Morrison Foerster.
  • Ferry joins Morrison Foerster from another leading international law firm, where he advised clients on life sciences, pharmaceutical, strategic IP, technology, data, and information-related transactions.
  • "Morrison Foerster is a well-known global life sciences and technology leader with exceptional life sciences and transactional capabilities and highly skilled attorneys," said Ferry.

Beverly Hills Fertility Opens as California's Newest, Most Innovative and Personal Fertility Center

Retrieved on: 
Thursday, May 12, 2022
Icahn School of Medicine at Mount Sinai, Physician, Brown University, Fertility, Fertility preservation, Patient, Genetic testing, Parent, Acupuncture, Fertilisation, BHF, Gynaecology, Suite, Micromanipulator, Embryo, UCLA School of Nursing, Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA, LOS, Hotel, Medical device, Infertility, Obstetrics

LOS ANGELES, May 12, 2022 /PRNewswire/ -- Beverly Hills Fertility (BHF), a new state-of-the art boutique fertility center, opens May 12 to serve hopeful parents in Southern California and around the world.

Key Points: 
  • Dr. Ellen Goldstein, Founding Medical Director, leads an experienced and compassionate team of professionals dedicated to fertility preservation and couples struggling with infertility.
  • LOS ANGELES, May 12, 2022 /PRNewswire/ -- Beverly Hills Fertility (BHF), a new state-of-the art boutique fertility center, opens May 12 to serve hopeful parents in Southern California and around the world.
  • Founding Medical Director Dr. Ellen Goldstein is double board certified in Obstetrics and Gynecology as well as Reproductive Endocrinology and Infertility.
  • Beverly Hills Fertility is located at 10390 Santa Monica Blvd, Suite 340, Los Angeles, CA 90025.

Dr. Eileen Fry-Bowers Appointed Dean of the University of San Francisco School of Nursing and Health Professions Effective July 1, 2022

Retrieved on: 
Thursday, April 14, 2022
Linda, American Academy of Nursing, University of San Francisco School of Nursing and Health Professions, Navy, Undergraduate research, USF, University of San Francisco, Bar association, Whittier Law School, Health equity, Adolescence, UCLA School of Nursing, University, Institutional review board, Loma Linda University, Research, Bulgarian–American Joint Military Facilities, Health policy, Public policy, Learning, Doctor of Philosophy, Education, Family, SAN, Social justice, Student, Health, State Bar of California, Policy, School, Optimism, Public health, American Academy, UCLA, Time, Medicine, Child, Nursing, USD

SAN FRANCISCO, April 14, 2022 /PRNewswire/ --The University of San Francisco (USF) has announced that nursing and public health leader, clinician, professor and administrator Dr. Eileen Fry-Bowers has been appointed to the role of dean of the School of Nursing and Health Professions (SONHP).

Key Points: 
  • SAN FRANCISCO, April 14, 2022 /PRNewswire/ --The University of San Francisco (USF) has announced that nursing and public health leader, clinician, professor and administrator Dr. Eileen Fry-Bowers has been appointed to the role of dean of the School of Nursing and Health Professions (SONHP).
  • "The pandemic marks an inflection point for nursing and the health professions," said Incoming Dean Fry-Bowers.
  • I am thrilled to be joining the University of San Francisco as dean of SONHP at this pivotal time."
  • The School of Nursing and Health Professions advances the mission of the university by leading in innovative solutions to health inequities and transforming healthcare using evidence-informed approaches.